SENSEX NIFTY
AstraZeneca Pharma Quarterly Results, AstraZeneca Pharma Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - AstraZeneca Pharma
AstraZeneca Pharma
BSE: 506820|NSE: ASTRAZEN|ISIN: INE203A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 31, 17:00
1176.30
12.1 (1.04%)
VOLUME 9,821
LIVE
NSE
Jul 31, 17:00
1180.30
15.3 (1.31%)
VOLUME 51,519
Download Annual Report PDF Format 2014 | 2013 | 2012 | 2011

Quarterly Results of AstraZeneca Pharma

------------------- in Rs. Cr. -------------------
Mar '15 Dec '14 Sep '14 Jun '14 Mar '14
Net Sales/Income from operations 120.80 108.12 114.55 125.57 114.15
Other Operating Income 47.75 0.08 0.12 0.07 0.00
Total Income From Operations 168.55 108.20 114.67 125.64 114.15
EXPENDITURE
Consumption of Raw Materials 11.69 0.83 5.93 8.33 14.35
Purchase of Traded Goods 17.77 61.54 42.45 45.52 55.81
Increase/Decrease in Stocks 25.13 -23.63 4.66 -0.15 -25.40
Power & Fuel -- -- -- -- --
Employees Cost 36.60 39.17 40.32 43.75 54.71
Depreciation 4.02 4.37 3.46 3.43 2.97
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 36.56 40.43 47.43 44.15 29.58
P/L Before Other Inc. , Int., Excpt. Items & Tax 36.78 -14.51 -29.57 -19.39 -17.87
Other Income 1.35 1.10 1.61 1.79 1.42
P/L Before Int., Excpt. Items & Tax 38.13 -13.41 -27.96 -17.60 -16.46
Interest -- -- -- -- --
P/L Before Exceptional Items & Tax 38.13 -13.41 -27.96 -17.60 -16.46
Exceptional Items -- -- -- -- 13.89
P/L Before Tax 38.13 -13.41 -27.96 -17.60 -2.57
Tax -- -- -- -- --
P/L After Tax from Ordinary Activities 38.13 -13.41 -27.96 -17.60 -2.57
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 38.13 -13.41 -27.96 -17.60 -2.57
Equity Share Capital 5.00 5.00 5.00 5.00 5.00
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 15.25 -5.36 -11.18 -7.04 -1.03
Diluted EPS 15.25 -5.36 -11.18 -7.04 -1.03
EPS After Extra Ordinary
Basic EPS 15.25 -5.36 -11.18 -7.04 -1.03
Diluted EPS 15.25 -5.36 -11.18 -7.04 -1.03
Public Share Holding
No Of Shares (Crores) 0.63 0.63 0.63 0.63 0.63
Share Holding (%) 25.00 25.00 25.00 25.00 25.00
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 1.88 1.88 1.88 1.88 1.88
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) 75.00 75.00 75.00 75.00 75.00
Notes
Source : Dion Global Solutions Limited
Quick Links for astrazenecapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.